Carol Harris, MD
Interventional Pain Medicine · Meridian, MSNPI 1710935671
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,155 of the $3,516 with a category attached, or 61.3%. Pacira Pharmaceuticals Incorporated accounts for 68.4% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $2,486, 5.6 times the $442 reported in 2019.
Across 50 payments — averaging $70.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- Abbott$463
- Medtronic$167
- Daiichi Sankyo Inc.$97
- Averitas Pharma Inc.$80
- Scilex Pharmaceuticals Inc.$73
- plus $231 from 8 others
What the payments were for
- Travel & lodging$2,15561%
- Food & beverage$1,36139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $2,406 |
| Abbott | 14 | $463 |
| Medtronic | 7 | $167 |
| Daiichi Sankyo Inc. | 2 | $97 |
| Averitas Pharma Inc. | 3 | $80 |
| Scilex Pharmaceuticals Inc. | 1 | $73 |
| Nevro Corp. | 4 | $54 |
| GRT US Holding, Inc. | 3 | $43 |
| Boston Scientific | 2 | $42 |
| Redhill Biopharma Inc. | 2 | $32 |
| Biodelivery Sciences International, Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$2,223
- Proclaim IPG$127
How this compares
$3,516 in reported general payments places this provider in the 60th percentile of 24 interventional pain medicine providers in Mississippi.
See all interventional pain medicine providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 838 | $17,607 |
| Gabapentin | 351 | $4,424 |
| Buprenorphine | 13 | $3,678 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 76 | $2,143 |
| Pregabalin | 69 | $1,454 |
| Tizanidine Hcl | 138 | $1,399 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 123 | $1,365 |
| Diclofenac Sodium | 23 | $1,127 |
| Cyclobenzaprine Hcl | 83 | $838 |
| Tramadol Hcl ErTramadol Hcl | 15 | $745 |
| Duloxetine Hcl | 48 | $710 |
| Tramadol Hcl | 106 | $557 |
| Amitriptyline Hcl | 50 | $463 |
| Celecoxib | 39 | $459 |
| Baclofen | 22 | $334 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Meridian
- Eric PearsonMeridian$19K
- Charles MartinMeridian$18K
- Kenneth StaggsMeridian$5K
- Leonel VanceMadison$21K
- Matthew BlanchardGulfport$10K
- Madelyn CraigMadison$5K
- John LutzJackson$5K
- Michael SteuerSouthaven$4K
- Kelly ColemanVancleave$4K
- Thomas YearwoodPascagoula$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.